US6897220B2
(en)
*
|
2001-09-14 |
2005-05-24 |
Methylgene, Inc. |
Inhibitors of histone deacetylase
|
CN101851173A
(zh)
*
|
2001-09-14 |
2010-10-06 |
梅特希尔基因公司 |
组蛋白脱乙酰化酶抑制剂
|
US7868204B2
(en)
*
|
2001-09-14 |
2011-01-11 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
ES2364645T3
(es)
|
2002-02-05 |
2011-09-08 |
Astellas Pharma Inc. |
Derivado de 2,4,6-triamino-1,3,5-triazina.
|
TWI319387B
(en)
|
2002-04-05 |
2010-01-11 |
Astrazeneca Ab |
Benzamide derivatives
|
GB0209715D0
(en)
*
|
2002-04-27 |
2002-06-05 |
Astrazeneca Ab |
Chemical compounds
|
US7351719B2
(en)
|
2002-10-31 |
2008-04-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
|
BRPI0410633A
(pt)
|
2003-05-23 |
2006-06-13 |
Zentaris Gmbh |
piridopirazinas e uso das mesmas como moduladores de cinase
|
DE10323345A1
(de)
|
2003-05-23 |
2004-12-16 |
Zentaris Gmbh |
Neue Pyridopyrazine und deren Verwendung als Kinase-Inhibitoren
|
MXPA06000794A
(es)
|
2003-07-22 |
2006-08-23 |
Astex Therapeutics Ltd |
Compuestos 1h-pirazola 3,4-disustituida y su uso como moduladores de quinasas dependientes de ciclina (cdk) y quinasa-3 de sintasa de glicogeno (gsr-3).
|
WO2005019188A1
(ja)
*
|
2003-08-22 |
2005-03-03 |
Takeda Pharmaceutical Company Limited |
縮合ピリミジン誘導体およびその用途
|
JP4809228B2
(ja)
*
|
2003-09-24 |
2011-11-09 |
メチルジーン インコーポレイテッド |
ヒストンデアセチラーゼの阻害剤
|
GB0322409D0
(en)
*
|
2003-09-25 |
2003-10-29 |
Astrazeneca Ab |
Quinazoline derivatives
|
US20050085531A1
(en)
*
|
2003-10-03 |
2005-04-21 |
Hodge Carl N. |
Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
|
JP4667384B2
(ja)
|
2003-10-07 |
2011-04-13 |
レノビス, インコーポレイテッド |
イオンチャネルリガンドとしてのアミド誘導体および薬学的組成物、ならびにこれらを使用する方法
|
WO2005034880A2
(en)
*
|
2003-10-09 |
2005-04-21 |
Aton Pharma, Inc. |
Thiophene and benzothiophene hydroxamic acid derivatives
|
CN1882345A
(zh)
|
2003-10-16 |
2006-12-20 |
希龙公司 |
作为raf激酶抑制剂以治疗癌症的2,6-二取代的喹唑啉、喹喔啉、喹啉和异喹啉
|
WO2005066151A2
(en)
*
|
2003-12-19 |
2005-07-21 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
WO2005065681A1
(en)
*
|
2003-12-19 |
2005-07-21 |
Takeda San Diego, Inc. |
N- hydroxy-3-(3-(1h-imidazol-2-yl)-phenyl)-acrylamide derivatives and related compounds as histone deacetylase (hdac) inhibitors for the treatment of cancer
|
US7592373B2
(en)
|
2003-12-23 |
2009-09-22 |
Boehringer Ingelheim International Gmbh |
Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
|
CA2553670A1
(en)
*
|
2004-01-29 |
2005-08-11 |
Elixir Pharmaceuticals, Inc. |
Anti-viral therapeutics
|
JP2007519754A
(ja)
*
|
2004-01-30 |
2007-07-19 |
スミスクライン ビーチャム コーポレーション |
化合物
|
RS52937B
(en)
|
2004-03-11 |
2014-02-28 |
4Sc Ag |
SULFONYLPYROLS AS HDAC INHIBITORS
|
EP1735319B1
(en)
*
|
2004-03-26 |
2017-05-03 |
MethylGene Inc. |
Inhibitors of histone deacetylase
|
TWI415606B
(zh)
*
|
2004-03-26 |
2013-11-21 |
Methylgene Inc |
組蛋白去乙醯基酶之抑制劑
|
US7253204B2
(en)
*
|
2004-03-26 |
2007-08-07 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
AR050926A1
(es)
*
|
2004-09-03 |
2006-12-06 |
Astrazeneca Ab |
Derivados de benzamida como inhibidores de la histonadesacetilasa(hdac)
|
US7776869B2
(en)
|
2004-10-18 |
2010-08-17 |
Amgen Inc. |
Heteroaryl-substituted alkyne compounds and method of use
|
WO2006066133A2
(en)
*
|
2004-12-16 |
2006-06-22 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
GB0501146D0
(en)
*
|
2005-01-20 |
2005-02-23 |
Astrazeneca Ab |
Novel benzamide derivatives
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
AR054425A1
(es)
|
2005-01-21 |
2007-06-27 |
Astex Therapeutics Ltd |
Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
|
WO2006081332A1
(en)
|
2005-01-25 |
2006-08-03 |
Epix Delaware, Inc. |
Substituted arylamine compounds and their use as 5-ht6 modulators
|
US7576099B2
(en)
|
2005-02-28 |
2009-08-18 |
Renovis, Inc. |
Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
|
JP5119143B2
(ja)
|
2005-03-15 |
2013-01-16 |
フォーエスシー アクチエンゲゼルシャフト |
N−スルホニルピロール類及びヒストンデアセチラーゼインヒビターとしてのそれらの使用
|
AU2006240248A1
(en)
*
|
2005-04-20 |
2006-11-02 |
Merck Sharp & Dohme Corp. |
Benzothiophene hydroxamic acid derivatives
|
EP1874294A4
(en)
*
|
2005-04-20 |
2010-12-01 |
Merck Sharp & Dohme |
HYDROXAMIC ACID DERIVATIVES OF BENZOTHIOPHENE WITH CARBAMATE, UREA, AMIDE AND SULFAMIDE SUBSTITUTIONS
|
JP2008536926A
(ja)
|
2005-04-20 |
2008-09-11 |
メルク エンド カムパニー インコーポレーテッド |
ベンゾチオフェン誘導体
|
US7642253B2
(en)
*
|
2005-05-11 |
2010-01-05 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
AU2006246958A1
(en)
*
|
2005-05-19 |
2006-11-23 |
Prometic Biosciences Inc. |
Triazine compounds and compositions thereof for the treatment of cancers
|
WO2008041053A2
(en)
|
2005-05-20 |
2008-04-10 |
Methylgene, Inc. |
Inhibitors of vegf receptor and hgf receptor signaling
|
DE102005027274A1
(de)
*
|
2005-06-08 |
2006-12-14 |
Schering Ag |
Inhibitoren der löslichen Adenylatzyklase
|
US7417066B2
(en)
|
2005-06-08 |
2008-08-26 |
Schering Ag |
Inhibitors of soluble adenylate cyclase
|
AU2006259525B2
(en)
|
2005-06-14 |
2012-05-24 |
Gpcr Therapeutics, Inc |
Pyrimidine compounds
|
US8193206B2
(en)
|
2005-06-14 |
2012-06-05 |
Taigen Biotechnology Co., Ltd. |
Pyrimidine compounds
|
JP4528918B2
(ja)
*
|
2005-06-21 |
2010-08-25 |
学校法人 関西大学 |
カルボキサミド誘導体
|
AU2006262166A1
(en)
|
2005-06-24 |
2007-01-04 |
Merck Sharp & Dohme Corp. |
Modified malonate derivatives
|
AU2006270322A1
(en)
|
2005-07-14 |
2007-01-25 |
Takeda San Diego, Inc. |
Histone deacetylase inhibitors
|
JP2009506069A
(ja)
|
2005-08-26 |
2009-02-12 |
ブレインセルス,インコーポレイティド |
ムスカリン性受容体調節による神経発生
|
EP2258359A3
(en)
|
2005-08-26 |
2011-04-06 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation with sabcomelin
|
CN101287706A
(zh)
|
2005-09-21 |
2008-10-15 |
尼科梅德有限责任公司 |
作为组蛋白脱乙酰基酶抑制剂的磺酰基吡咯盐酸盐
|
CA2622673C
(en)
|
2005-09-21 |
2017-06-27 |
Thomas Maier |
Sulphonylpyrroles and use thereof as inhibitors of hdac s
|
GB0521244D0
(en)
|
2005-10-19 |
2005-11-30 |
Astrazeneca Ab |
Benzamide compounds
|
JP2009512711A
(ja)
|
2005-10-21 |
2009-03-26 |
ブレインセルス,インコーポレイティド |
Pde阻害による神経新生の調節
|
EP1942879A1
(en)
|
2005-10-31 |
2008-07-16 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
KR101400905B1
(ko)
|
2005-11-11 |
2014-05-29 |
아에테르나 젠타리스 게엠베하 |
신규한 피리도피라진 및 키나제의 조절제로서의 이의 용도
|
US8217042B2
(en)
|
2005-11-11 |
2012-07-10 |
Zentaris Gmbh |
Pyridopyrazines and their use as modulators of kinases
|
EP1790342A1
(de)
|
2005-11-11 |
2007-05-30 |
Zentaris GmbH |
Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege
|
AR057579A1
(es)
|
2005-11-23 |
2007-12-05 |
Merck & Co Inc |
Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
|
AU2007221207A1
(en)
|
2006-02-28 |
2007-09-07 |
Merck Sharp & Dohme Corp. |
Inhibitors of histone deacetylase
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
CA2648804C
(en)
|
2006-04-07 |
2014-05-27 |
Methylgene Inc. |
Benzamide derivatives as inhibitors of histone deacetylase
|
JP2009535333A
(ja)
*
|
2006-04-26 |
2009-10-01 |
メルク エンド カムパニー インコーポレーテッド |
二置換アニリン化合物
|
EP2021000A2
(en)
|
2006-05-09 |
2009-02-11 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
AU2007249435A1
(en)
|
2006-05-09 |
2007-11-22 |
Braincells, Inc. |
5 HT receptor mediated neurogenesis
|
EP2023924B1
(en)
|
2006-05-18 |
2016-08-03 |
Merck Sharp & Dohme Corp. |
Aryl-fused spirocyclic compounds
|
EP2049124A4
(en)
|
2006-07-20 |
2010-02-10 |
Merck & Co Inc |
PHOSPHOR DERIVATIVES AS HISTONDEACETYLASE HEMMER
|
AU2007292848A1
(en)
|
2006-09-08 |
2008-03-13 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
CN103275067B
(zh)
|
2006-10-28 |
2015-09-02 |
梅特希尔基因公司 |
组蛋白脱乙酰酶抑制剂
|
JP5622393B2
(ja)
|
2006-12-15 |
2014-11-12 |
アブラクシスバイオサイエンス リミテッド ライアビリティー カンパニー |
トリアジン誘導体類及びそれらの治療応用
|
WO2008104869A1
(en)
|
2007-02-26 |
2008-09-04 |
Pfizer Products Inc. |
Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
|
US8030344B2
(en)
|
2007-03-13 |
2011-10-04 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
EP2170339B1
(en)
|
2007-06-27 |
2014-10-15 |
Merck Sharp & Dohme Corp. |
Pyridyl and pyrimidinyl derivatives as histone deacetylase inhibitors
|
US8389553B2
(en)
|
2007-06-27 |
2013-03-05 |
Merck Sharp & Dohme Corp. |
4-carboxybenzylamino derivatives as histone deacetylase inhibitors
|
NZ584279A
(en)
|
2007-09-19 |
2011-11-25 |
4Sc Ag |
Novel tetrahydrofusedpyridines as histone deacetylase inhibitors
|
JP5322477B2
(ja)
*
|
2007-09-28 |
2013-10-23 |
富士フイルム株式会社 |
新規アセチレン化合物、その塩、その製造方法、それを構成単位として含むポリマー、該ポリマーの製造方法、該ポリマーの組成物、該ポリマー組成物を硬化させてなる硬化物
|
WO2009040290A1
(en)
|
2007-09-27 |
2009-04-02 |
F. Hoffmann-La Roche Ag |
Quinoline derivatives as 5ht5a receptor antagonists
|
CA2702536A1
(en)
*
|
2007-10-10 |
2009-04-16 |
Orchid Research Laboratories Limited |
Novel histone deacetylase inhibitors
|
BRPI0817860A2
(pt)
*
|
2007-10-22 |
2019-09-24 |
Orchid Res Laboratories Limited |
inibidores de histona deacetilase
|
EP2060565A1
(en)
*
|
2007-11-16 |
2009-05-20 |
4Sc Ag |
Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
|
CA2711995A1
(en)
*
|
2008-01-29 |
2009-08-06 |
F. Hoffmann-La Roche Ag |
Novel n-(2-amino-phenyl)-amide derivatives
|
NZ588989A
(en)
*
|
2008-04-21 |
2012-03-30 |
Taigen Biotechnology Co Ltd |
Heterocyclic compounds comprising pyrimidine, piperazine and amine.
|
MX2010012297A
(es)
*
|
2008-05-16 |
2010-12-06 |
Hoffmann La Roche |
Nuevas n-(2-amino-fenil)-acrilamidas.
|
NZ588511A
(en)
|
2008-05-23 |
2012-04-27 |
Novartis Ag |
Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors
|
EP2292611B1
(en)
*
|
2008-05-23 |
2012-07-25 |
Santen Pharmaceutical Co., Ltd |
Novel thiophenediamine derivative having urea structure
|
KR20110014229A
(ko)
|
2008-05-27 |
2011-02-10 |
더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 |
Wnt 단백질 신호전달 억제제
|
AU2009289649B2
(en)
|
2008-09-03 |
2016-05-05 |
Biomarin Pharmaceutical Inc. |
Compositions including 6-aminohexanoic acid derivatives as HDAC inhibitors
|
US8202866B2
(en)
*
|
2008-09-17 |
2012-06-19 |
Hoffmann-La Roche Inc. |
Ortho-aminoanilides for the treatment of cancer
|
SI3135672T1
(sl)
*
|
2008-10-10 |
2020-07-31 |
Vm Discovery, Inc. |
Sestavki in postopki za zdravljenje motenj, bolečin in drugih bolezni povezanih z uporabo alkohola
|
RU2011119478A
(ru)
|
2008-10-14 |
2012-11-27 |
Нин Си |
Соединения и способы применения
|
WO2010056847A2
(en)
|
2008-11-13 |
2010-05-20 |
Taigen Biotechnology Co., Ltd. |
Lyophilization formulation
|
US8748623B2
(en)
|
2009-02-17 |
2014-06-10 |
Syntrix Biosystems, Inc. |
Pyridinecarboxamides as CXCR2 modulators
|
WO2010099217A1
(en)
|
2009-02-25 |
2010-09-02 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
CN101906076B
(zh)
*
|
2009-06-04 |
2013-03-13 |
深圳微芯生物科技有限责任公司 |
作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物、其制备方法及应用
|
CN102573480B
(zh)
|
2009-06-09 |
2015-06-10 |
加利福尼亚资本权益有限责任公司 |
三嗪衍生物及其治疗应用
|
KR20120026612A
(ko)
|
2009-06-09 |
2012-03-19 |
아브락시스 바이오사이언스, 엘엘씨 |
벤질 치환 트리아진 유도체와 이들의 치료적 용도
|
KR20120026611A
(ko)
*
|
2009-06-09 |
2012-03-19 |
아브락시스 바이오사이언스, 엘엘씨 |
헷지호그 신호전달의 피리딜-트리아진 억제제
|
US8784873B2
(en)
*
|
2009-07-22 |
2014-07-22 |
Naturewise Biotech & Medicals Corporation |
Use of histone deacetylase inhibitors in changing MRJP3 protein in royal jelly
|
JP2011057661A
(ja)
*
|
2009-08-14 |
2011-03-24 |
Bayer Cropscience Ag |
殺虫性カルボキサミド類
|
WO2011053876A1
(en)
|
2009-10-30 |
2011-05-05 |
Massachusetts Institute Of Technology |
The use of ci-994 and dinaline for the treatment of memory/cognition and anxiety disorders
|
MX2012013274A
(es)
|
2010-05-21 |
2013-05-28 |
Chemilia Ab |
Novedosos derivados de la pirimidina.
|
EP2608672B1
(en)
|
2010-08-23 |
2020-12-16 |
Syntrix Biosystems, Inc. |
Aminopyridine- and aminopyrimidinecarboxamides as cxcr2 modulators
|
AU2010363329A1
(en)
|
2010-11-07 |
2013-05-09 |
Targegen, Inc. |
Compositions and methods for treating myelofibrosis
|
US10059723B2
(en)
|
2011-02-28 |
2018-08-28 |
Biomarin Pharmaceutical Inc. |
Histone deacetylase inhibitors
|
US8957066B2
(en)
|
2011-02-28 |
2015-02-17 |
Biomarin Pharmaceutical Inc. |
Histone deacetylase inhibitors
|
MY181439A
(en)
|
2011-02-28 |
2020-12-22 |
Sunshine Lake Pharma Co Ltd |
Substituted quinoline compounds and methods of use
|
ES2712803T3
(es)
*
|
2011-02-28 |
2019-05-14 |
Biomarin Pharm Inc |
Inhibidores de histona desacetilasa
|
US9006241B2
(en)
|
2011-03-24 |
2015-04-14 |
Noviga Research Ab |
Pyrimidine derivatives
|
EP2508184A1
(en)
|
2011-04-06 |
2012-10-10 |
Æterna Zentaris GmbH |
Pyridopyrazine derivatives and their use
|
CN102775356B
(zh)
*
|
2011-05-13 |
2015-07-22 |
江苏恒谊药业有限公司 |
4-氨基喹唑啉衍生物及其应用
|
CN102807526B
(zh)
*
|
2011-06-21 |
2015-12-02 |
寿光富康制药有限公司 |
组蛋白去乙酰化酶抑制剂ZYJ-D08a及其差向异构体的制备方法与应用
|
CN102838625B
(zh)
*
|
2011-06-22 |
2015-04-15 |
中国科学院上海药物研究所 |
四氢吡啶并噻唑类化合物、其制备方法、包含该化合物的药物组合物及其用途
|
CN102276554B
(zh)
*
|
2011-06-28 |
2013-10-30 |
四川大学 |
4-((2-氨基-5-巯基-1,3,4-噻二唑)-甲基)-苯甲酰胺衍生物及其制备方法和用途
|
EA201490228A1
(ru)
*
|
2011-07-08 |
2014-08-29 |
Новартис Аг |
Новые производные трифторметилоксадиазола и их применение для лечения заболевания
|
EA201490407A1
(ru)
|
2011-07-29 |
2014-05-30 |
Кариофарм Терапевтикс, Инк. |
Содержащие гидразид модуляторы нуклеарного транспорта и их применения
|
PE20141003A1
(es)
*
|
2011-07-29 |
2014-09-02 |
Karyopharm Therapeutics Inc |
Moduladores del transporte nuclear y usos de los mismos
|
AU2012345557A1
(en)
*
|
2011-11-28 |
2014-06-26 |
Novartis Ag |
Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease
|
JP5881460B2
(ja)
*
|
2012-02-23 |
2016-03-09 |
公立大学法人名古屋市立大学 |
新規アミド化合物及びその用途
|
WO2013137371A1
(ja)
*
|
2012-03-15 |
2013-09-19 |
興和株式会社 |
新規ピリミジン化合物及びそれらを含有する医薬
|
MX364992B
(es)
|
2012-05-09 |
2019-05-17 |
Biogen Ma Inc |
Moduladores del transporte nuclear y usos de los mismos.
|
WO2013184806A1
(en)
|
2012-06-05 |
2013-12-12 |
University Of Kansas |
Inhibitors of respiratory syncytial virus
|
WO2014022116A2
(en)
|
2012-07-28 |
2014-02-06 |
Calitor Sciences, Llc |
Substituted pyrazolone compounds and methods of use
|
TWI574962B
(zh)
|
2012-11-14 |
2017-03-21 |
加拓科學公司 |
作爲pi3激酶調節劑的芳雜環化合物及其使用方法和用途
|
EP2935217B1
(en)
|
2012-12-21 |
2019-02-27 |
Celgene Quanticel Research, Inc. |
Histone demethylase inhibitors
|
US9139583B2
(en)
|
2013-02-01 |
2015-09-22 |
Acetylon Pharmaceuticals, Inc. |
Selective HDAC3 inhibitors
|
JP2016511237A
(ja)
*
|
2013-02-01 |
2016-04-14 |
アセチロン ファーマシューティカルズ インコーポレイテッドAcetylon Pharmaceuticals,Inc. |
選択的hdac3阻害剤
|
MX2015010700A
(es)
|
2013-02-21 |
2017-01-23 |
Calitor Sciences Llc |
Compuestos heteroaromaticos como moduladores de la p13 cinasa.
|
WO2014144772A1
(en)
|
2013-03-15 |
2014-09-18 |
Karyopharm Therapeutics Inc. |
Methods of promoting wound healing using crm1 inhibitors
|
ES2680224T3
(es)
|
2013-03-15 |
2018-09-05 |
Biomarin Pharmaceutical Inc. |
Inhibidores de HDAC
|
PL3010892T3
(pl)
|
2013-06-21 |
2019-07-31 |
Karyopharm Therapeutics, Inc. |
1,2,4-triazole jako modulatory transportu jądrowego i ich zastosowania
|
US8969365B2
(en)
|
2013-08-02 |
2015-03-03 |
Syntrix Biosystems, Inc. |
Thiopyrimidinecarboxamides as CXCR1/2 modulators
|
US10561676B2
(en)
|
2013-08-02 |
2020-02-18 |
Syntrix Biosystems Inc. |
Method for treating cancer using dual antagonists of CXCR1 and CXCR2
|
US10046002B2
(en)
|
2013-08-02 |
2018-08-14 |
Syntrix Biosystems Inc. |
Method for treating cancer using chemokine antagonists
|
EP2853532B1
(en)
*
|
2013-09-28 |
2020-12-09 |
Instytut Farmakologii Polskiej Akademii Nauk |
1,2,4-oxadiazole derivatives as allosteric modulators of metabotropic glutamate receptors belonging to group III
|
US9428495B2
(en)
|
2013-10-14 |
2016-08-30 |
Eisai R&D Management Co., Ltd. |
Selectively substituted quinoline compounds
|
MX363708B
(es)
|
2013-10-14 |
2019-03-29 |
Eisai R&D Man Co Ltd |
Compuestos de quinolina selectivamente sustituidos.
|
WO2015058106A1
(en)
*
|
2013-10-18 |
2015-04-23 |
The General Hospital Corporation |
Imaging histone deacetylases with a radiotracer using positron emission tomography
|
US9988343B2
(en)
*
|
2013-11-05 |
2018-06-05 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of histone deacetylase
|
US9636298B2
(en)
|
2014-01-17 |
2017-05-02 |
Methylgene Inc. |
Prodrugs of compounds that enhance antifungal activity and compositions of said prodrugs
|
EP3738960A1
(en)
|
2014-06-25 |
2020-11-18 |
Celgene Quanticel Research, Inc. |
Histone demethylase inhibitors
|
RU2732416C2
(ru)
*
|
2014-07-31 |
2020-09-16 |
Институт Пастер Корея |
Производные 2-амино-бензимидазола и их использование в качестве ингибиторов 5-липоксигеназы и/или простагландин е-синтазы
|
ES2926377T3
(es)
*
|
2014-08-15 |
2022-10-25 |
Karyopharm Therapeutics Inc |
Polimorfos de selinexor
|
KR20180022840A
(ko)
*
|
2015-07-02 |
2018-03-06 |
바이오마린 파머수티컬 인크. |
히스톤 데아세틸라제 저해제
|
JP6812426B2
(ja)
|
2015-10-19 |
2021-01-13 |
サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. |
Egfr阻害剤の塩、結晶形及びその使用
|
EP3397634A1
(en)
|
2015-12-31 |
2018-11-07 |
Karyopharm Therapeutics, Inc. |
Nuclear transport modulators and uses thereof
|
WO2017117529A1
(en)
|
2015-12-31 |
2017-07-06 |
Karyopharm Therapeutics Inc. |
Nuclear transport modulators and uses thereof
|
AU2017262920B2
(en)
|
2016-05-12 |
2021-05-20 |
Luoda Biosciences, Inc. |
Novel 2,4,6-trisubstituted s-triazine compound, preparation method therefor, and use thereof
|
CN106242992A
(zh)
*
|
2016-07-25 |
2016-12-21 |
北京化工大学 |
一种苯甲酰胺类化合物及其在制备抑制癌细胞增殖和/或治疗癌症的药物中的应用
|
CN106496053B
(zh)
*
|
2016-09-22 |
2018-01-05 |
潍坊医学院 |
一种组蛋白去乙酰酶抑制剂n‑(2’‑胺基苯基)‑4‑(双(2‑氯乙基)胺基)苯甲酰胺及其制备方法和应用
|
US10660909B2
(en)
|
2016-11-17 |
2020-05-26 |
Syntrix Biosystems Inc. |
Method for treating cancer using chemokine antagonists
|
US11602530B2
(en)
|
2016-11-28 |
2023-03-14 |
Biogen Ma Inc. |
CRM1 inhibitors for treating epilepsy
|
TW201829381A
(zh)
*
|
2016-12-22 |
2018-08-16 |
美商拜奧馬林製藥公司 |
組蛋白脫乙醯基酶抑制劑
|
WO2018165520A1
(en)
|
2017-03-10 |
2018-09-13 |
Vps-3, Inc. |
Metalloenzyme inhibitor compounds
|
CN107141244B
(zh)
*
|
2017-05-08 |
2019-11-19 |
潍坊医学院 |
吲哚丁酸类组蛋白去乙酰酶抑制剂及其制备方法和应用
|
RU2019136536A
(ru)
*
|
2017-05-16 |
2021-06-16 |
Аннцзи Фармасьютикал Ко., Лтд. |
Ингибиторы гистондеацетилаз (hdac)
|
US11230524B2
(en)
*
|
2017-08-17 |
2022-01-25 |
Standard Llc |
Myocyte enhancer factor 2 (MEF2) modulators
|
CN107459480A
(zh)
*
|
2017-09-05 |
2017-12-12 |
镇江斯格派医疗器械有限公司 |
一种双芳基脲类组蛋白去乙酰化酶抑制剂
|
KR101964810B1
(ko)
|
2017-10-12 |
2019-04-02 |
충북대학교 산학협력단 |
Hdac 억제제로서 신규한 퀴나졸린-4(3h)-원 기반 n-하이드록시벤즈아미드 또는 n-하이드록시프로펜아미드 및 이를 유효성분으로 포함하는 항암제 조성물
|
WO2019097515A1
(en)
|
2017-11-15 |
2019-05-23 |
Metabomed Ltd |
Acss2 inhibitors and methods of use thereof
|
CN108570012B
(zh)
*
|
2018-05-23 |
2021-11-12 |
中南大学 |
1,3-苯并噁嗪-2,4(3h)-二酮衍生物及其合成方法和用途
|
CN109020951B
(zh)
*
|
2018-08-24 |
2020-06-02 |
大连理工大学 |
含三取代三聚氯氰的萘酰亚胺类衍生物及其合成方法和应用
|
CN109336871A
(zh)
*
|
2018-10-31 |
2019-02-15 |
南京先进生物材料与过程装备研究院有限公司 |
一种stat3抑制剂的马来酸盐及其制备方法与用途
|
CN109293647A
(zh)
*
|
2018-10-31 |
2019-02-01 |
南京先进生物材料与过程装备研究院有限公司 |
二苯并[b,d]噻吩类STAT3抑制剂的M晶型及其制备方法
|
CN109369628A
(zh)
*
|
2018-10-31 |
2019-02-22 |
南京先进生物材料与过程装备研究院有限公司 |
咔唑类stat3抑制剂晶型ii及其制备方法
|
CN109336867A
(zh)
*
|
2018-10-31 |
2019-02-15 |
南京先进生物材料与过程装备研究院有限公司 |
咔唑类stat3抑制剂晶型a及其制备方法
|
CN109180656A
(zh)
*
|
2018-10-31 |
2019-01-11 |
南京先进生物材料与过程装备研究院有限公司 |
一类stat3抑制剂及其应用
|
CN109336876A
(zh)
*
|
2018-10-31 |
2019-02-15 |
南京先进生物材料与过程装备研究院有限公司 |
二苯并[b,d]噻吩类STAT3抑制剂的酒石酸盐及其制备方法与用途
|
CN109336869A
(zh)
*
|
2018-10-31 |
2019-02-15 |
南京先进生物材料与过程装备研究院有限公司 |
一种stat3抑制剂的甲磺酸盐及其制备方法与用途
|
CN110078722A
(zh)
*
|
2018-10-31 |
2019-08-02 |
南京先进生物材料与过程装备研究院有限公司 |
一种噻吨酮类stat3抑制剂马来酸盐晶型a及其应用
|
CN109336877A
(zh)
*
|
2018-10-31 |
2019-02-15 |
南京先进生物材料与过程装备研究院有限公司 |
二苯并[b,d]噻吩类STAT3抑制剂的甲磺酸盐及其制备方法与用途
|
CN109369626A
(zh)
*
|
2018-10-31 |
2019-02-22 |
南京先进生物材料与过程装备研究院有限公司 |
咔唑类stat3抑制剂p晶型及其制备方法
|
CN109336870A
(zh)
*
|
2018-10-31 |
2019-02-15 |
南京先进生物材料与过程装备研究院有限公司 |
咔唑类stat3抑制剂晶型i及其制备方法
|
EP3983386A4
(en)
*
|
2019-05-14 |
2023-01-11 |
Metabomed Ltd |
ACSS2 INHIBITORS AND METHODS OF USE
|
CN111116469A
(zh)
*
|
2019-12-27 |
2020-05-08 |
北京鑫开元医药科技有限公司 |
一种hdac抑制剂、制备方法、药物组合物及其用途
|
CN113549057B
(zh)
*
|
2020-04-24 |
2023-01-31 |
中国药科大学 |
Snail抑制剂及其衍生物,制备方法、药物组合物和应用
|
CN115403483B
(zh)
*
|
2021-07-02 |
2024-01-26 |
河南省儿童医院郑州儿童医院 |
含二苯乙烯或二苯甲酮骨架的ca-4衍生物、药物组合物及其制备方法和应用
|
CN114539180A
(zh)
*
|
2021-12-24 |
2022-05-27 |
贵州大学 |
一种含异噁唑啉的双酰胺类化合物及其制备方法和用途
|